Cambridge Investment Research Advisors’s Surgalign Holdings, Inc. Common Stock SRGA Stock Holding History

Cambridge Investment Research Advisors’s Portfolio SRGA Stock Details SRGA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-482	Closed	-$41K	–	2495
2019 Q3	$41K	Buy	+482	New	+$51.5K	﹤0.01%	2291
2019 Q2	–	Sell	-2,744	Closed	-$495K	–	2398
2019 Q1	$495K	Buy	+2,744	New	+$397K	﹤0.01%	1481
2016 Q2	–	Sell	-358	Closed	-$43K	–	1693
2016 Q1	$43K	Hold	358	–	–	﹤0.01%	1562
2015 Q4	$43K	Buy	+358	New	+$46.2K	﹤0.01%	1536

Other funds holding SRGA

PCMI

Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

KFO

Kopp Family Office Bloomington, Minnesota $163M AUM 22.57% 1-Year Est. Return

KAM

Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

HPM

HealthCor Partners Management Charleston, South Carolina $50.7M AUM

Cambridge Investment Research Advisors's SRGA Position: Q4 2019 in Review

Cambridge Investment Research Advisors sold out of Surgalign Holdings, Inc. Common Stock (SRGA) in Q4 2019, closing a stake of 482 shares — an estimated $41K sold.

Cambridge Investment Research Advisors first reported a position in SRGA in Q4 2015 and held it in 4 quarters. The position peaked at $495K in Q1 2019. 88 funds tracked by Wall St. Rank hold SRGA as of Q4 2019.

Cambridge Investment Research Advisors reported no remaining Surgalign Holdings, Inc. Common Stock position as of Q4 2019 after selling out during the quarter.
Cambridge Investment Research Advisors sold 482 Surgalign Holdings, Inc. Common Stock shares in Q4 2019, an estimated $41K.
Cambridge Investment Research Advisors first reported a position in Surgalign Holdings, Inc. Common Stock in Q4 2015 and held it in 4 quarters.
Cambridge Investment Research Advisors's Surgalign Holdings, Inc. Common Stock position peaked at $495K in Q1 2019.
88 funds tracked by Wall St. Rank held Surgalign Holdings, Inc. Common Stock as of Q4 2019.

Based on Cambridge Investment Research Advisors's 13F filing for Q4 2019, filed 4 Feb 2020.